This list contains only the countries for which job offers have been published in the selected language (e.g., in the French version, only job offers written in French are displayed, and in the English version, only those in English).
The Director, Investor Relations & External Communications will play a critical role in shaping how Cabaletta Bio is understood by the investment community and external stakeholders during a period of significant value creation. Reporting to the Chief Financial Officer, with a dotted line to the Chief Business Officer, this individual will lead the development and execution of Cabaletta Bio’s investor relations and external communications strategy. This highly visible role will partner closely with executive leadership to ensure that our scientific progress, clinical milestones, and long-term vision are translated into clear, compelling, and credible narratives. We are seeking a strategic and hands-on leader who is equally comfortable engaging with investors and building internal alignment across functions, and who brings a strong understanding of the complexities and opportunities inherent in autologous cell therapy.
Job Responsibility
Develop and execute an integrated investor relations and external communications strategy aligned with Cabaletta Bio’s corporate milestones, including BLA submission and commercialization readiness
Partner with executive leadership to shape, refine, and consistently communicate Cabaletta Bio’s investment thesis and corporate narrative
Serve as a trusted advisor to the CFO, CBO, and CEO on messaging, positioning, and engagement with the investment community
Build scalable processes and infrastructure to support Cabaletta Bio’s evolution into a commercial-stage organization
Serve as a primary point of contact for investors and analysts, fostering strong, long-term relationships across the investment community
Lead preparation of earnings materials, investor presentations, and key external communications
Support capital markets activities, including financings, investor targeting, and roadshows
Monitor market dynamics, peer landscape, analyst coverage, and investor sentiment to inform strategy and leadership decision-making
Provide ongoing insights to executive leadership regarding valuation drivers and investor expectations
Track and schedule investor interactions and provide insights into future interactions
Own and ensure consistency of messaging across all external channels, including press releases, investor materials, and corporate content
Translate complex clinical, regulatory, and scientific developments into clear, accessible, and compelling narratives
Support communications related to clinical milestones, regulatory interactions, and business development activities
Partner with external agencies to enhance Cabaletta Bio’s visibility and ensure alignment of messaging
Support executive visibility, conference participation, and thought leadership opportunities
Work closely with Clinical, Regulatory, R&D, Commercial, and Business Development teams to ensure alignment between internal progress and external messaging
Support preparation for investor meetings, earnings calls, and key external engagements
Ensure consistent, thoughtful communication during critical inflection points, including clinical readouts and regulatory milestones
Requirements
Bachelor's degree required
10+ years of experience in investor relations, equity research, investment banking, or corporate communications within biotech or life sciences
Direct experience in autologous cell therapy required
Strong understanding of biotech capital markets, investor expectations, and value drivers
Demonstrated ability to synthesize complex scientific and clinical information into clear, compelling messaging
Experience engaging with institutional investors, analysts, and executive leadership
Ability to operate effectively in a fast-paced, collaborative, and evolving environment
Nice to have
Advanced degree (PhD, MD, MBA, or related) preferred
Experience supporting companies through late-stage clinical development, BLA/NDA submission, or commercialization preferred
What we offer
Competitive benefits including health and retirement, PTO, and stock option plans